Granules Pharmaceuticals, a wholly-owned subsidiary of Granules India, has received tentative approval from the US Food and ...

Please provide your email address to receive an email when new articles are posted on . This three-part blog series has focused on generic medications in ophthalmology. In our first post, we explored ...

Granules said on December 22, 2025 it had received a tentative approval for the Amphetamine Extended-Release Orally ...

Findings from the GATE study have shown equivalent efficacy and tolerability for a generic version of glatiramer acetate to that of the original brand version in the treatment of relapsing–remitting ...

A decision handed down by the Alabama Supreme Court rules brand-name drug makers can be held liable if consumers experience adverse effects from that drug’s generic equivalent. The decision stems from ...

PINE BROOK, N.J.--(BUSINESS WIRE)--Today, Alvogen has launched the first generic equivalent to Tamiflu® (oseltamivir phosphate) capsules in the United States. Alvogen expects the generic equivalent to ...

The Skinny Labels, Big Savings Act was introduced on January 9 in an effort to provide “a statutory safe harbor from patent ...

WASHINGTON (Reuters) - The White House Medical Unit during the Trump administration provided prescription drugs, including controlled substances, to ineligible staff and spent tens of thousands of ...

As insurance companies push doctors to save money by switching their patients to generic drugs, complaints about those generics appear to be on the upswing. That’s the observation of journalist ...

New US Food and Drug Administration (FDA)–sponsored studies indicate that generic versions of lamotrigine are pharmacokinetically equivalent to the original drug, providing some reassurance that ...

PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced the launch of the first generic equivalent of Zoladex TM in Central and Eastern Europe. The product will be marketed in two strengths (3.6mg ...